Profil
Greg Whitehead worked as a Director of Bioanalytic Chemistry at Emergent BioDefense Operations Lansing, Inc., a Director of Corporate Quality at Dendreon Pharmaceuticals LLC, and a Vice President of Quality at bluebird bio, Inc. He also served as the Chief Quality Officer and Senior Vice President at Rubius Therapeutics, Inc. from 2019 to 2022.
Whitehead received his undergraduate degree from Michigan State University.
Anciens postes connus de Greg Whitehead
| Sociétés | Poste | Fin |
|---|---|---|
| RUBIUS THERAPEUTICS | Corporate Officer/Principal | 01/09/2022 |
Emergent BioDefense Operations Lansing, Inc.
 Emergent BioDefense Operations Lansing, Inc. BiotechnologyHealth Technology Emergent BioDefense Operations Lansing, Inc. was engaged in manufacturing human vaccines to prevent rabies and anthrax. The company was headquartered in Baltimore, MD. | Corporate Officer/Principal | - |
Dendreon Pharmaceuticals LLC
 Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Dendreon Pharmaceuticals LLC is a commercial-stage biopharmaceutical company that specializes in developing, manufacturing, and commercializing cell therapies. Dendreon Pharmaceuticals is based in Seal Beach, CA. The private company is a pioneer in cellular therapy, targeting cancer and transforming lives. Dendreon has proven expertise in cellular therapy and ensures product quality through its experience in the field. The company was founded in 1992 by Edgar G. Engleman and Samuel Strober, and the CEO is John C O'Neill. | Corporate Officer/Principal | - |
| BLUEBIRD BIO, INC. | Corporate Officer/Principal | - |
Formation de Greg Whitehead
| Michigan State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Emergent BioDefense Operations Lansing, Inc.
Emergent BioDefense Operations Lansing, Inc. BiotechnologyHealth Technology Emergent BioDefense Operations Lansing, Inc. was engaged in manufacturing human vaccines to prevent rabies and anthrax. The company was headquartered in Baltimore, MD. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Dendreon Pharmaceuticals LLC
Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Dendreon Pharmaceuticals LLC is a commercial-stage biopharmaceutical company that specializes in developing, manufacturing, and commercializing cell therapies. Dendreon Pharmaceuticals is based in Seal Beach, CA. The private company is a pioneer in cellular therapy, targeting cancer and transforming lives. Dendreon has proven expertise in cellular therapy and ensures product quality through its experience in the field. The company was founded in 1992 by Edgar G. Engleman and Samuel Strober, and the CEO is John C O'Neill. | Health Technology |
